Product Name

  • Name

    Alendronate sodium

  • EINECS 601-766-4
  • CAS No. 121268-17-5
  • Article Data20
  • CAS DataBase
  • Density 1.857 g/cm3
  • Solubility Water, double-distilled: 10 mg/mL
  • Melting Point 245 °C(lit.)
  • Formula C4H12NNaO7P2.3(H2O)
  • Boiling Point 616.7 °C at 760 mmHg
  • Molecular Weight 271.079
  • Flash Point 326.7 °C
  • Transport Information
  • Appearance white crystalline solid
  • Safety 26-36-60
  • Risk Codes 22-36/37/38
  • Molecular Structure Molecular Structure of 121268-17-5 (Alendronate sodium)
  • Hazard Symbols Xn,Xi
  • Synonyms (4-Amino-1-hydroxy-1-phosphono-butyl)phosphonic acid; sodium;Fosamax (TN);Alendronate sodium hydrate;sodium [4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)butyl]phosphonic acid trihydrate;Alendronate sodium hydrate (JAN);Alendronate Sodium (Fosamax);Alendronate Sodium BP;G-704,650;MK-217;
  • PSA 211.45000
  • LogP -0.32760

Synthetic route

4-amino-n-butyric acid
56-12-2

4-amino-n-butyric acid

sodium alendronate
121268-17-5

sodium alendronate

Conditions
ConditionsYield
Stage #1: 4-amino-n-butyric acid With phosphonic Acid; methanesulfonic acid; phosphorus trichloride at 65℃;
Stage #2: With water Reflux;
Stage #3: With sodium hydroxide In water
91%
With phosphorous acid; phosphorus trichloride In methanesulfonic acid at 65℃;82%
Stage #1: 4-amino-n-butyric acid With 1-butyl-3-methylimidazolium Tetrafluoroborate; phosphorous acid; phosphorus trichloride In sulfolane at 75℃; for 3h;
Stage #2: With water In sulfolane at 105℃; for 3h;
Stage #3: With sodium hydroxide In sulfolane at 0 - 25℃; for 14h; pH=4.6; Reagent/catalyst;
80%
tetraethyl 2-N-phthalimide-1-hydroxybutylidene-1,1-bisphosphonate
183959-44-6

tetraethyl 2-N-phthalimide-1-hydroxybutylidene-1,1-bisphosphonate

sodium alendronate
121268-17-5

sodium alendronate

Conditions
ConditionsYield
Stage #1: tetraethyl 2-N-phthalimide-1-hydroxybutylidene-1,1-bisphosphonate With hydrogenchloride Heating;
Stage #2: With sodium hydroxide pH=4.3 - 4.4;
90%
2-pyrrolidinon
616-45-5

2-pyrrolidinon

sodium alendronate
121268-17-5

sodium alendronate

Conditions
ConditionsYield
Stage #1: 2-pyrrolidinon With phosphorus trichloride In water at 65 - 110℃; for 7.33333 - 7.41667h;
Stage #2: With methanesulfonic acid; phosphorus trichloride at 60 - 75℃; for 9h;
Stage #3: With sodium hydroxide; water Product distribution / selectivity; more than 3 stages;
82%
Stage #1: 2-pyrrolidinon With water; phosphorus trichloride at 65 - 110℃; for 7.33333 - 7.41667h; Heating / reflux;
Stage #2: With methanesulfonic acid; phosphorus trichloride at 60 - 75℃; for 9h;
Stage #3: With sodium hydroxide; methanesulfonic acid; water Product distribution / selectivity; more than 3 stages;
82%
Stage #1: 2-pyrrolidinon With methanesulfonic acid; water; phosphorus trichloride at 20 - 110℃; for 3.33333 - 8.41667h; Heating / reflux;
Stage #2: With methanesulfonic acid at 60 - 75℃; for 9h;
Stage #3: With sodium hydroxide; methanesulfonic acid; water Product distribution / selectivity; more than 3 stages;
81%
4-amino-1-hydroxybutylidenebisphosphonic acid
66376-36-1

4-amino-1-hydroxybutylidenebisphosphonic acid

sodium alendronate
121268-17-5

sodium alendronate

Conditions
ConditionsYield
With sodium carbonate In water for 3h; Heating;79%
With sodium hydroxide In water at 0 - 5℃; for 3h; pH=4.3;
With sodium hydroxide In water at 30 - 70℃;
sodium hydroxide
1310-73-2

sodium hydroxide

sodium alendronate
121268-17-5

sodium alendronate

Conditions
ConditionsYield
Stage #1: 4-amino-n-butyric acid With phosphorous acid; phosphorus trichloride In acetonitrile at 55 - 75℃; for 6 - 9h;
Stage #2: With water In acetonitrile at 60 - 100℃; for 4 - 6h;
Stage #3: sodium hydroxide at 55 - 65℃; pH=4.4 - 4.8;
69.6%
C13H31NO8P2Si

C13H31NO8P2Si

sodium alendronate
121268-17-5

sodium alendronate

Conditions
ConditionsYield
Stage #1: C13H31NO8P2Si With hydrogenchloride In water for 17h; Reflux;
Stage #2: With sodium hydroxide In water at 25℃; pH=4.3;
26.84 g
carbon disulfide
75-15-0

carbon disulfide

sodium alendronate
121268-17-5

sodium alendronate

sodium alendronate dithiocarbamate

sodium alendronate dithiocarbamate

Conditions
ConditionsYield
Stage #1: sodium alendronate With sodium hydroxide In water Cooling with ice;
Stage #2: carbon disulfide In water for 24h; Cooling with ice;
95%
With sodium hydroxide In water at 0℃; for 24h;94%
C18H26N4O12

C18H26N4O12

sodium alendronate
121268-17-5

sodium alendronate

C18H34N4O16P2

C18H34N4O16P2

Conditions
ConditionsYield
With triethylamine In water at 20℃; for 24h;92%
2,5-dioxopyrrolidin-1-yl pent-4-ynoate
132178-37-1

2,5-dioxopyrrolidin-1-yl pent-4-ynoate

sodium alendronate
121268-17-5

sodium alendronate

1-hydroxy-4-pent-4-ynamidobutane-1,1-diyldiphosphonic acid
952615-43-9

1-hydroxy-4-pent-4-ynamidobutane-1,1-diyldiphosphonic acid

Conditions
ConditionsYield
Stage #1: sodium alendronate With sodium hydroxide In water pH=8.5;
Stage #2: 2,5-dioxopyrrolidin-1-yl pent-4-ynoate In water; acetonitrile at 22℃; for 8h; pH=8.5;
89.9%
4-nitro-benzoyl chloride
122-04-3

4-nitro-benzoyl chloride

sodium alendronate
121268-17-5

sodium alendronate

Na(1+)*C11H15N2O10P2(1-)

Na(1+)*C11H15N2O10P2(1-)

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water at 20℃; for 2h; pH=11;86%
2,3-bis(benzyloxy)benzoyl chloride
69146-58-3

2,3-bis(benzyloxy)benzoyl chloride

sodium alendronate
121268-17-5

sodium alendronate

4-N-(2,3-dibenzyloxybenzoyl)aminobutane-1-hydroxy-1,1-bisphosphonic acid disodium

4-N-(2,3-dibenzyloxybenzoyl)aminobutane-1-hydroxy-1,1-bisphosphonic acid disodium

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran at 20℃; for 6h;81.2%
diethylenetriaminepentaacetic dianhydride
23911-26-4

diethylenetriaminepentaacetic dianhydride

sodium alendronate
121268-17-5

sodium alendronate

C22H43N5O22P4(2-)*2Na(1+)

C22H43N5O22P4(2-)*2Na(1+)

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 60℃; for 12h; pH=8; Inert atmosphere;80%
6-azidohexanoic acid 2,5-dioxo-pyrrolidin-1-yl ester
866363-70-4

6-azidohexanoic acid 2,5-dioxo-pyrrolidin-1-yl ester

sodium alendronate
121268-17-5

sodium alendronate

[4-(6-azidohexanamido)-1-hydroxy-1-(hydroxy-oxido-phosphoryl)butyl]phosphonic acid sodium salt

[4-(6-azidohexanamido)-1-hydroxy-1-(hydroxy-oxido-phosphoryl)butyl]phosphonic acid sodium salt

Conditions
ConditionsYield
With sodium hydroxide In water; acetonitrile at 20℃; pH=Ca. 8.5;80%
With sodium hydroxide In water; acetonitrile at 20℃; for 25h; pH=8 - 8.5;70%
tert-butoxycarbonyl-L-proline N-hydroxysuccinimide ester
3392-10-7

tert-butoxycarbonyl-L-proline N-hydroxysuccinimide ester

sodium alendronate
121268-17-5

sodium alendronate

C14H28N2O10P2

C14H28N2O10P2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In water; N,N-dimethyl-formamide at 20℃; for 96h;75%
6-aza-5,9-dioxo-9-(1,2-didehydrodibenzo[b,f]azocin-5(6H)-yl)nonanoic acid succinimidyl ester
1393350-27-0

6-aza-5,9-dioxo-9-(1,2-didehydrodibenzo[b,f]azocin-5(6H)-yl)nonanoic acid succinimidyl ester

sodium alendronate
121268-17-5

sodium alendronate

C23H26N2O9P2

C23H26N2O9P2

Conditions
ConditionsYield
With sodium hydroxide In water; dimethyl sulfoxide at 5℃; Darkness;66%
5-(1H-imidazol-1-yl)pentanoic acid
68887-65-0

5-(1H-imidazol-1-yl)pentanoic acid

sodium alendronate
121268-17-5

sodium alendronate

[1-hydroxy-4-(5-imidazol-1-ylpentanoylamino)-1-phosphonobutyl]phosphonic acid

[1-hydroxy-4-(5-imidazol-1-ylpentanoylamino)-1-phosphonobutyl]phosphonic acid

Conditions
ConditionsYield
Stage #1: sodium alendronate With N-ethyl-N,N-diisopropylamine In water at 20℃; for 0.5h;
Stage #2: 5-(1H-imidazol-1-yl)pentanoic acid With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate In water; N,N-dimethyl-formamide
42%
trans-4-cycloocten-yl 2,5-dioxo-1-pyrrolidinyl ester carbonic acid

trans-4-cycloocten-yl 2,5-dioxo-1-pyrrolidinyl ester carbonic acid

sodium alendronate
121268-17-5

sodium alendronate

[4-(cyclooct-4-enyloxycarbonylamino)-1-hydroxy-1-phosphonobutyl]phosphonic acid

[4-(cyclooct-4-enyloxycarbonylamino)-1-hydroxy-1-phosphonobutyl]phosphonic acid

Conditions
ConditionsYield
With triethylamine In water; dimethyl sulfoxide Darkness;25%
copper(II) nitrate trihydrate

copper(II) nitrate trihydrate

galium(III) nitrate monohydrate

galium(III) nitrate monohydrate

ethanol
64-17-5

ethanol

C17H26N6O5

C17H26N6O5

sodium alendronate
121268-17-5

sodium alendronate

sodium hydroxide
1310-73-2

sodium hydroxide

C21H34CuGaN7O12P2*4NO3(1-)*4Na(1+)*7.1C2H6O

C21H34CuGaN7O12P2*4NO3(1-)*4Na(1+)*7.1C2H6O

Conditions
ConditionsYield
Stage #1: copper(II) nitrate trihydrate; galium(III) nitrate monohydrate; C17H26N6O5 In water for 0.25h;
Stage #2: sodium alendronate In water for 0.25h;
Stage #3: ethanol; sodium hydroxide Further stages;
23%
sodium alendronate
121268-17-5

sodium alendronate

3,5-dihexadecyloxybenzoic acid chloride
41696-89-3

3,5-dihexadecyloxybenzoic acid chloride

4-N-(3,5-ditetradecyloxybenzoyl)-aminobutane-1-hydroxy-1,1-bisphosphonic acid disodium salt

4-N-(3,5-ditetradecyloxybenzoyl)-aminobutane-1-hydroxy-1,1-bisphosphonic acid disodium salt

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; diethyl ether; water at 20℃; for 6h;13%
benzyl chloroformate
501-53-1

benzyl chloroformate

sodium alendronate
121268-17-5

sodium alendronate

4-benzyloxycarbonylamino-1-hydroxybutylidene-1,1-bisphosphonic acid
134399-26-1

4-benzyloxycarbonylamino-1-hydroxybutylidene-1,1-bisphosphonic acid

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 36h;
sodium alendronate
121268-17-5

sodium alendronate

4-amino-1-hydroxybutylidenebisphosphonic acid
66376-36-1

4-amino-1-hydroxybutylidenebisphosphonic acid

Conditions
ConditionsYield
With hydrogenchloride; ethanol; water at 20 - 50℃; for 2h;
sodium alendronate
121268-17-5

sodium alendronate

alendronate monosodium trihydrate

alendronate monosodium trihydrate

Conditions
ConditionsYield
With water at 58 - 60℃; pH=4.3 - 4.4;
2-chloromethylpyridine hydrochloride
6959-47-3

2-chloromethylpyridine hydrochloride

sodium alendronate
121268-17-5

sodium alendronate

C16H21N3O7P2(2-)*2Na(1+)

C16H21N3O7P2(2-)*2Na(1+)

Conditions
ConditionsYield
With sodium hydroxide In water at 20℃; for 40h; pH=12.1;> 90 %Chromat.
tetra(n-butyl)ammonium hydroxide
2052-49-5

tetra(n-butyl)ammonium hydroxide

sodium alendronate
121268-17-5

sodium alendronate

sodium tris(tetrabutylammonium) alendronate

sodium tris(tetrabutylammonium) alendronate

Conditions
ConditionsYield
In water
sodium alendronate
121268-17-5

sodium alendronate

calcium alendronate monohydrate

calcium alendronate monohydrate

Conditions
ConditionsYield
With calcium chloride; sodium hydroxide In water at 90℃; for 2h; Reagent/catalyst; Temperature; Time; Concentration;
sodium alendronate
121268-17-5

sodium alendronate

Methacryloyl chloride
920-46-7

Methacryloyl chloride

methacrylamide alendronate

methacrylamide alendronate

Conditions
ConditionsYield
With 4-methoxy-phenol; sodium hydroxide In water at 5 - 20℃; for 3h;
sodium alendronate
121268-17-5

sodium alendronate

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C42H70O35*C4H12NO7P2(1-)*Na(1+)

C42H70O35*C4H12NO7P2(1-)*Na(1+)

Conditions
ConditionsYield
In water for 0.05h;
formaldehyd
50-00-0

formaldehyd

sodium alendronate
121268-17-5

sodium alendronate

acetylacetone
123-54-6

acetylacetone

C15H24NO9P2(1-)*Na(1+)

C15H24NO9P2(1-)*Na(1+)

Conditions
ConditionsYield
In aq. acetate buffer pH=5; Solvent; Temperature; Time; pH-value; Hantzsch Dihydropyridine Synthesis; Heating;
sodium alendronate
121268-17-5

sodium alendronate

4-Nitrobenzenesulfonyl chloride
98-74-8

4-Nitrobenzenesulfonyl chloride

Na(1+)*C10H15N2O11P2S(1-)

Na(1+)*C10H15N2O11P2S(1-)

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water at 20℃; for 2h; pH=10 - 11;

Alendronate sodium Chemical Properties

Empirical Formula: C4H18NNaO10P2
Molecular Weight: 325.1237
Nominal Mass: 325 Da
Average Mass: 325.1237 Da
Monoisotopic Mass: 325.030363 Da 
Flash Point: 326.7 °C
Enthalpy of Vaporization: 104.87 kJ/mol
Boiling Point: 616.7 °C at 760 mmHg
Vapour Pressure: 8.72E-18 mmHg at 25 °C
Melting point: 245 °C(lit.)
Storage tempreture: -20 °C
Solubility: Water, double-distilled: 10 mg/mL
Appearance: White crystalline solid
Structure of Alendronate sodium (CAS NO.121268-17-5):
                            
IUPAC Name: Sodium (4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate trihydrate
Canonical SMILES: C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.O.O.O.[Na+]
InChI: InChI=1S/C4H13NO7P2.Na.3H2O/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;;;;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);;3*1H2/q;+1;;;/p-1
InChIKey: DCSBSVSZJRSITC-UHFFFAOYSA-M
Product Category of 2-Chloro-5-nitroanisole (CAS NO.1009-36-5): Miscellaneous Biochemicals;Osteoporosis;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Miscellaneous Compounds

Alendronate sodium Uses

 Alendronate sodium (CAS NO.121268-17-5)  is a bisphosphonate drug used for osteoporosis and several other bone diseases. And it used for prophylaxis and in treatment of female and male osteoporosis. It has been used for prevention and treatment of corticosteroid-associated osteoporosis together with supplements of calcium and vitamin D, and used for paget's disease.

Alendronate sodium Toxicity Data With Reference

1.    

ivn-rat LDLo:30 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 28 (1994),3229.
2.    

ivn-dog LDLo:10 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 28 (1994),3229.

Alendronate sodium Safety Profile

A poison by intravenous route. Experimental reproductive effects. When heated to decomposition it emits toxic vapors of NOx, POx, and NaO.
Hazard Codes: HarmfulXn,IrritantXi
The Risk Statements:
22:  Harmful if swallowed 
36/37/38:  Irritating to eyes, respiratory system and skin
The Safety Statements:
26:  In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 
36:  Wear suitable protective clothing  
WGK Germany: 3

Alendronate sodium Specification

 Alendronate sodium , its cas register number is 121268-17-5. It also can be called Fosamax ; Monosodium alendronate ; Alendronic acid monosodium salt ; Fosalan ; Alendros ; Bifosa ; NeoBon ; 4-Amino-1-hydroxybutylidene-1,1-bisphosphonic acid monosodium salt ; and Osteovan . It is marketed alone as well as in combination with vitamin D, and Merck's U.S. patent on alendronate expired in 2008 and Merck lost a series of appeals to block a generic version of the drug from being certified by the U.S. Food and Drug Administration (FDA). Alendronate inhibits osteoclast-mediated bone-resorption.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View